These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16817515)

  • 1. Optimization of sample size in controlled experiments: the CLAST rule.
    Botella J; Ximénez C; Revuelta J; Suero M
    Behav Res Methods; 2006 Feb; 38(1):65-76. PubMed ID: 16817515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the CLAST sequential rule to one-way ANOVA under group sampling.
    Ximénez C; Revuelta J
    Behav Res Methods; 2007 Feb; 39(1):86-100. PubMed ID: 17552475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of sequential sampling for meta-analysis.
    Braschi L; Botella J; Suero M
    Behav Res Methods; 2014 Dec; 46(4):1167-83. PubMed ID: 24399083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable criteria sequential stopping rule: Validity and power with repeated measures ANOVA, multiple correlation, MANOVA and relation to Chi-square distribution.
    Fitts DA
    Behav Res Methods; 2018 Oct; 50(5):1988-2003. PubMed ID: 28936614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved stopping rules for the design of efficient small-sample experiments in biomedical and biobehavioral research.
    Fitts DA
    Behav Res Methods; 2010 Feb; 42(1):3-22. PubMed ID: 20160281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variable-criteria sequential stopping rule: generality to unequal sample sizes, unequal variances, or to large ANOVAs.
    Fitts DA
    Behav Res Methods; 2010 Nov; 42(4):918-29. PubMed ID: 21139159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-arm group sequential designs with a simultaneous stopping rule.
    Urach S; Posch M
    Stat Med; 2016 Dec; 35(30):5536-5550. PubMed ID: 27550822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.
    Jacob L; Uvarova M; Boulet S; Begaj I; Chevret S
    BMC Med Res Methodol; 2016 Jun; 16():67. PubMed ID: 27250349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical comparison of group-sequential and adaptive designs.
    Kelly PJ; Sooriyarachchi MR; Stallard N; Todd S
    J Biopharm Stat; 2005; 15(4):719-38. PubMed ID: 16022175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian sequential design with binary outcome.
    Zhu H; Yu Q; Mercante DE
    Pharm Stat; 2017 May; 16(3):192-200. PubMed ID: 28251815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four hundred or more participants needed for stable contingency table estimates of clinical prediction rule performance.
    Kent P; Boyle E; Keating JL; Albert HB; Hartvigsen J
    J Clin Epidemiol; 2017 Feb; 82():137-148. PubMed ID: 27847252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing computer adaptive testing stopping rules under the generalized partial-credit model.
    Stafford RE; Runyon CR; Casabianca JM; Dodd BG
    Behav Res Methods; 2019 Jun; 51(3):1305-1320. PubMed ID: 29926441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequentist implications of optional stopping on Bayesian hypothesis tests.
    Sanborn AN; Hills TT
    Psychon Bull Rev; 2014 Apr; 21(2):283-300. PubMed ID: 24101570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient group sequential designs when there are several effect sizes under consideration.
    Jennison C; Turnbull BW
    Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in designing flexible trials.
    Posch M; Bauer P; Brannath W
    Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequentist evaluation of group sequential clinical trial designs.
    Emerson SS; Kittelson JM; Gillen DL
    Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the triangular test with response-adaptive treatment allocation.
    Coad DS; Ivanova A
    Stat Med; 2005 May; 24(10):1483-93. PubMed ID: 15706635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.